The positive correlations between DOK2 and immune checkpoint genes, including HAVCR2, PD-L2, and CTLA4 among others, could be potential mechanisms for immune escape and immunotherapy in AML. The gene discussed is HAVCR2; the disease is acute myeloid leukemia.